GlassScriptPhysician profile
Ralph Delnegro
NPI 1033297155
$3,542.77
in general payments reported to CMS, 2019-2025
26 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $53.89 · 2021: $278 · 2022: $955 · 2023: $472 · 2024: $638 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,811 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,811.23 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $1,397.37 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $428.84 | 2019-2025 | Rocklatan, Hydrus Microstent, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $424.65 | 2021-2025 | Tecnis Iol, Tecnis Iol |
| Rxsight INC | $186.71 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $171.98 | 2022-2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $137.53 | 2019-2021 | |
| Dutch Ophthalmic, USA | $90.69 | 2025 | Eva, Combined Machine, Tissueblue |
| Bausch & Lomb Americas INC. | $81.05 | 2022-2025 | Vyzulta |
| Allergan, INC. | $78.35 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $75.89 | 2019-2021 | |
| Abbvie INC. | $60.88 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $51.53 | 2019 | |
| Biotissue Holdings INC. | $46.31 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.16 | 2019-2021 | |
| Lensar, INC. | $32.99 | 2025 | Lensar Laser System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $32.36 | 2023 | |
| Eyepoint US, INC. | $31.38 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $31.25 | 2019-2025 | |
| Thea Pharma INC. | $29.12 | 2023-2024 | Iyuzeh |
| Dompe US, INC. | $18.09 | 2025 | Oxervate |
| Omeros Corporation | $17.35 | 2019 | |
| Harrow Eye, LLC | $16.94 | 2025 | Vevye |
| New World Medical,INC. | $16.40 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Rayner Intraocular Lenses Limited | $15.46 | 2023 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Iridex Corporation | $14.75 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Delnegro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.